Lab Monitoring and KDIGO Targets in SHPT

Monitoring secondary hyperparathyroidism (SHPT) is not about achieving a single “perfect” number on a blood test. Because kidney disease affects your minerals and hormones in a constantly shifting balance, medical experts—specifically the KDIGO (Kidney Disease: Improving Global Outcomes) organization—emphasize looking at trends over time ^[1][2].

A single high reading might be a temporary spike, but a “persistent and progressive” rise in your levels is the signal your doctor uses to adjust your treatment ^[1][3].

The Core Lab Markers

To get a complete picture of your bone and mineral health (CKD-MBD), your care team monitors several key markers:

• Intact Parathyroid Hormone (iPTH): This measures how hard your parathyroid glands are working. In kidney disease, this number is often higher than in a healthy person ^[4].
• Calcium and Phosphorus (Phosphate): These minerals should be balanced. High phosphorus often “drives” the parathyroid glands to work harder, but low or high calcium also strongly influences treatment choices ^[4][1].
• Alkaline Phosphatase (Alk Phos): Routine blood work often checks “Total Alkaline Phosphatase,” which can be affected by the liver as well as the bones. Your doctor may also check “Bone-Specific Alkaline Phosphatase,” a more targeted marker that tracks how fast your bone is being broken down and rebuilt. Neither test alone diagnoses your exact bone status, but together with PTH, they help your clinician understand your bone turnover ^[5][6].
• 25-Hydroxyvitamin D: This measures your “nutritional” vitamin D stores, which help your body manage calcium ^[3].

Different Targets for Different Stages

Your “target” numbers change depending on whether you are managing kidney disease with diet and medication or if you have started dialysis.

Non-Dialysis (CKD Stages 3-5)

For patients not yet on dialysis, there is no single optimal PTH target ^[4]. Instead of trying to force your PTH into a specific range, doctors focus on “modifiable factors” ^[1]. This means they will treat high phosphate, low calcium, or vitamin D deficiency first to see if the PTH stabilizes on its own ^[4].

Dialysis (CKD Stage 5D)

Once you are on dialysis, the suggested targets change. The goal is not to bring your PTH down to the “normal” range of a healthy person ^[7]. The KDIGO guidelines suggest maintaining PTH at 2 to 9 times the laboratory’s upper limit of normal ^[7][8]. This is a suggested management range, not a strict biological requirement, and it accounts for assay variability and the complex needs of dialysis patients.

• Example: If your lab says the “normal” upper limit is 65 pg/mL, a suggested range on dialysis might be roughly 130 to 585 pg/mL.

The Danger of “Oversuppression”

It might seem like “lower is better” for a hormone, but suppressing PTH too much in dialysis patients can be dangerous ^[7]. If PTH drops too low, it can contribute to adynamic bone disease ^[8].

In this condition, your bones become “quiet” and stop the natural process of recycling and renewing themselves. This makes the bone brittle, increasing your risk of fractures and potentially contributing to vascular calcification (calcium depositing in blood vessels) ^[7][1].

Completeness Checklist: Your Lab Review

Monitoring frequency is individualized—some patients need labs every month, others every few months. At your check-ups, review the following “trends” with your team:

1. [ ] Intact PTH: Is it rising consistently over the last several months?
2. [ ] Phosphorus: Is it staying within the target range for my CKD stage?
3. [ ] Calcium: Are we avoiding “hypercalcemia” (too much calcium) from supplements or medications? ^[1]
4. [ ] Alkaline Phosphatase: Is this enzyme trending up or down alongside my PTH? ^[5]
5. [ ] Vitamin D: Have we checked my 25-hydroxyvitamin D levels recently, and am I taking my supplements correctly? ^[3]